Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Completed 120Terminated 19Withdrawn 5Active not recruiting 5Unknown 4Suspended 1

Sponsor Class

OTHER 12INDUSTRY 5NIH 3NETWORK 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 4Head & Neck 1

Conditions

Carcinoma, Hepatocellular 4Neoplasms 2Thyroid Neoplasms 1Carcinoma 1

Interventions

pembrolizumab 184Carboplatin 132Paclitaxel 101Cisplatin 101Gemcitabine 86Pemetrexed 79durvalumab 75Nivolumab 66Docetaxel 56atezolizumab 52Bevacizumab 50Cyclophosphamide 49Dexamethasone 45Capecitabine 45Oxaliplatin 43130-nm albumin-bound paclitaxel 41Rituximab 40Fulvestrant 39Lenalidomide 38Fluorouracil 38Prednisone 32osimertinib 31olaparib 29Leucovorin 29venetoclax 28fludarabine 28Trastuzumab 27Doxorubicin 27Etoposide 25Cetuximab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Active not recruiting × INDUSTRY × Sorafenib × Clear all
NCT02185560 2026-04-14

JPMS-DTC

Bayer

Active not recruiting
453 enrolled
Head & Neck

Thyroid Neoplasms

NCT04039607 2026-04-06

CheckMate 9DW

Bristol-Myers Squibb

Phase 3 Active not recruiting
732 enrolled 1 FDA
Gastrointestinal

Carcinoma, Hepatocellular

NCT03298451 2026-03-20

HIMALAYA

AstraZeneca

Phase 3 Active not recruiting
1,324 enrolled 31 charts 1 FDA
Gastrointestinal

Carcinoma, Hepatocellular

NCT03755791 2025-12-11

COSMIC-312

Exelixis

Phase 3 Active not recruiting
837 enrolled 14 charts
Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Neoplasms

NCT05822752 2025-08-14

LIVIGNO-1

AbbVie

Phase 2 Active not recruiting
130 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡